Roopal Thakkar
Förmögenhet: 13 M $ per 2026-02-28
Förmögenhet: 13 M $ per 2026-02-28
Roopal Thakkar currently works at AbbVie, Inc., as Chief Scientific Officer, Executive VP-R&D from 2024.
Dr. Thakkar also formerly worked at Global Therapeutics, Inc., as Chief Medical Officer & Senior Vice President.
Dr. Thakkar received his undergraduate degree from the University of Michigan and doctorate degree from Wayne State University School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ABBVIE, INC. 0 % | 2026-02-27 | 55 374 ( 0 % ) | 13 M $ | 2026-02-28 |
| Företag | Position | Start |
|---|---|---|
| ABBVIE INC. | Teknisk/Vetenskaplig/F&U Direktör | 2003-01-01 |
| Företag | Position | Slut |
|---|---|---|
Global Therapeutics, Inc.
Global Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in advanced medical devices | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Global Therapeutics, Inc.
Global Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in advanced medical devices | Commercial Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wayne State University School of Medicine
Wayne State University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
MarketScreener is also available in this country: United States.
Switch edition